Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
18 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-releases-2024-annual-report-with-revenue-exceeding-rmb-200m-in-1st-year-of-commercialization-and-innovative-portfolio-accelerating-toward-launch-302432475.html
06 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asieris-and-cdc-sign-investigational-product-supply-agreement-for-apl-1202-in-free-living-amoeba-infections-treatment-under-expanded-access-investigational-new-drug-program-302342872.html
30 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/photocure-partner-asieris-unveils-cevira-apl-1702-phase-iii-subgroup-analysis-by-age-groups-at-the-2024-csco-annual-meeting-302262265.html
28 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-releases-2024-semi-annual-report-highlighting-steady-progress-in-launching-blockbuster-product-for-precancerous-cervical-lesions-and-continued-strengthening-of-commercial-revenue-generation-capabilities-302232982.html
17 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/revir-therapeutics-reaches-milestone-in-novel-splicing-therapy-development-in-collaboration-with-asieris-pharmaceuticals-302171821.html
17 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-unveils-2023-annual-report-core-product-apl-1702-succeeds-in-global-phase-iii-clinical-trials-apl-1706-obtains-nda-acceptance-domestically-specialty-commercial-team-generates-sustained-revenue-streams-302119669.html
ABOUT THIS PAGE